MedTrace Logo

Outpatient Treatment of Alcohol Withdrawal Syndrome

NCT00136617 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2009-03-02

No results posted yet for this study

Summary

The purpose of this study is to compare a fixed-schedule therapy versus a symptom-triggered therapy for alcohol withdrawal syndrome in medical outpatients.

Objectives:

* Self-governance in monitoring AWS (alcohol withdrawal syndrome) symptoms and medication
* Clinically controlled trial of two regimens for medical treatment of alcohol withdrawal syndrome
* Outpatient treatment of alcohol withdrawal syndrome

Conditions

  • Alcoholism
  • Alcohol Withdrawal

Interventions

DRUG

chlordiazepoxide

Sponsors & Collaborators

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Ulrik Becker, MD · Hvidovre University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2006-07-31
Completion
2008-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00136617 on ClinicalTrials.gov